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Abstract
Electrolyte imbalances are common among patients with traumatic brain injury (TBI). Cerebral salt wasting (CSW) is
an electrolyte imbalance characterized by hyponatremia and hypovolemia. Differentiating the syndrome of
inappropriate antidiuretic hormone and CSW remains difficult and the pathophysiological mechanisms underlying
CSW are unclear. Our intent was to review the literature on CSW within the TBI population, in order to report the
incidence and timing of CSW after TBI, examine outcomes, and summarize the biochemical changes in patients
who developed CSW. We searched MEDLINE through 2014, hand-reviewed citations, and searched abstracts
from the American Association for the Surgery of Trauma (2003–2014). Publications were included if they
were conducted within a TBI population, presented original data, and diagnosed CSW. Publications were
excluded if they were review articles, discussed hyponatremia but did not differentiate the etiology causing
hyponatremia, or presented cases with chronic disease. Fifteen of the 47 publications reviewed met the
selection criteria; nine (60 %) were case reports, five (33 %) were prospective and 1 (7 %) was a retrospective
study. Incidence of CSW varied between 0.8 - 34.6 %. The populations studied were heterogeneous and the
criteria used to define hyponatremia and CSW varied. Though believed to play a role in the development of
CSW, increased levels of natriuretic peptides in patients diagnosed with CSW were not consistently reported.
These findings reinforce the elusiveness of the CSW diagnosis and the need for strict and consistent diagnostic criteria.
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Introduction
Brain injury or illness, including traumatic brain injury
(TBI), is frequently associated with perturbations in
water balance including hyponatremia [1]. When hypo-
natremia accompanies acute brain pathology, the differ-
ential diagnosis includes fluid volume depletion, effects
of certain medications, syndrome of inappropriate anti-
diuretic hormone (SIADH), and salt wasting syndromes,
in particular cerebral salt wasting (CSW).
First described by Peters et al. in 1950 [2], CSW is
characterized by a renal loss of sodium following
intracranial disorders, resulting in hyponatremia and
hypovolemia [1, 3–5]. CSW is complex and poorly
understood; it can easily be confused with SIADH and
the aforementioned differential diagnoses. A clinician’s
ability to promptly distinguish CSW is crucial; the
emergent therapy for all of these conditions is similar
(hypertonic saline and/or 0.9 % saline), but sub-acute
therapy with vaptans, a class of drugs that antagonize
vasopressin receptors, is contraindicated in salt wasting
states [6]. Additionally, hypovolemia in CSW necessi-
tates replacement of sodium and water, whereas the
combination of hyponatremia and excess fluid in SIADH
is treated via water restriction. If left untreated, severe
hyponatremia can result in seizures and worsening cere-
bral edema [7]. When hyponatremia is suboptimally
treated, the patient is at an increased risk of delayed
ischemic deficits and/or osmotic demyelination leading
to disability and excess mortality [8].
The mechanisms leading to CSW have yet to be clearly
defined and no single etiology is believed to be the sole
cause of CSW. It is hypothesized that CSW develops
because of increased levels of natriuretic peptides and
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changes in the sympathetic nervous system, the renin-
angiotensin-aldosterone system, and adrenomedullin [7].
CSW is most frequently studied in patients with
aneurysmal subarachnoid hemorrhage (aSAH) [5]. This
population experiences a high incidence of hyponatre-
mia, observed in up to 57 % of patients [9]. Although
TBI is also associated with hyponatremia, CSW has
rarely been studied in the TBI population, and much of
the literature consists of case reports, reviews and small
cohort studies that focus on incidence, etiology, and bio-
chemical changes. Little information is available on out-
comes in patients with CSW after TBI.
Our objective was to review the literature on CSW
within the TBI population in order to define the inci-
dence and timing of CSW after TBI, examine outcomes,




We performed a methodical search of the CSW med-
ical literature through 2014 using the online database
MEDLINE. Initial search criteria phrases included
“cerebral salt wasting” AND “traumatic brain injury”
OR “head trauma”; the search was limited to English-
language publications. Citations from published articles
were hand-reviewed and we searched abstracts from the
American Association for the Surgery of Trauma (AAST)
using the AAST online collection of past abstracts
(2003–2014).
Studies were included in this review if they: 1) were
conducted within patients who suffered a TBI, 2) pre-
sented original data by way of case reports, prospective
and retrospective observational studies, or randomized
controlled clinical trials, and 3) diagnosed cerebral salt
wasting. Publications were excluded if they were review
articles, discussed hyponatremia but did not differentiate
the etiology causing hyponatremia, or were case reports
in patients with chronic disease.
The Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) Statement [10] checklist
was used to ensure appropriate collection of variables.
For this review we collected and tabulated informa-
tion on publication year and source, study design,
study size, patient inclusion and exclusion criteria, pa-
tient demographics, cause of TBI, results of head
computed tomography (CT) scans, and patient out-
comes. We recorded levels of atrial natriuretic peptide
(ANP), brain natriuretic peptide (BNP), antidiuretic
hormone (ADH), aldosterone, cortisol, adrenocortico-
tropic hormone (ACTH), and plasma renin activity in
order to summarize biochemical changes that are po-
tentially part of the pathophysiological pathway lead-
ing to CSW.
Results
Study identification and selection
A total of 36 unique articles were initially identified
through electronic database search, 0 through a search
of conference abstracts, and 11 through hand search-
ing citations, resulting in 47 total publications (Fig. 1).
The initial review eliminated 21 publications that were
either review articles or were clearly not conducted in
TBI patients. Twenty-six full text articles were then
assessed for eligibility and eleven additional publica-
tions were excluded for not meeting study selection
criteria.
Fifteen of 47 (32 %) publications remained in our re-
view (Additional files 1 and 2). Nine (60 %) of the publi-
cations were case reports that presented a total of 10
cases, five (33 %) were prospective and 1 (7 %) was a
retrospective study. Seven of the fifteen (47 %) articles
were published in a neurology or neurosurgery journal
[11–17], six (40 %) were in a pediatric journal [17–22]
and the remainder were published within journals of
varied specialties [23–25].
Patient inclusion
Patient population was inconsistently defined across
cohort studies (Additional files 1 and 2). Five of the 9
case reports (56 %) were from American institutions
[16, 17, 21, 22, 25]. The remaining case reports and
cohort studies were conducted worldwide. Studies
were published over a 24 year span (1988–2011). Of
the six cohort studies, one study was conducted in
pediatric patients [18], one study included patients
aged ≥20 years [11], and the remaining four studies did
not mention specific age requirements and included pa-
tients ranging from 0 – 92 years old [12–14, 23]. Eight of
the 10 presented cases were of patients under the age of
18 [17, 19–22, 24, 25]. One study examined a population
of severely injured patients, defined as those with brain in-
jury and a Glasgow Coma Score (GCS) less than 9 [12].
Two studies excluded spinal cord injuries [11, 13] and
three studies excluded concomitant chronic conditions
such as renal, thyroid, and adrenal disease, hypertension,
and cardiopathy [11, 12, 23].
While all patients suffered a TBI, the particular type
varied (Additional files 1 and 2). Among patients with
any hyponatremia, Lohani et al. observed thirty-three
percent of patients had more than one lesion; intrapar-
enchymal lesions were most frequent (89 %), followed by
epidural lesions (33 %), pneumocephalus (22 %), and
traumatic subarachnoid hemorrhage (tSAH, 11 %) [11].
Moro et al. found patients with any hyponatremia expe-
rienced cerebral contusions (46 %), chronic subdural
hematomas (28 %), acute subdural hematomas (16 %),
acute epidural hematomas (8 %), and diffuse axonal in-
juries (1 %) [13].
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Incidence of cerebral salt wasting
The incidence of CSW after TBI ranged from 0.8 to
34.6% (Additional file 1) and was highest in the study
restricted to patients with a GCS less than nine [12].
Unfortunately, CSW was not consistently or always
concretely defined. Diagnoses of CSW in three of the
cohort studies were made when the following criteria
were observed: 1) hyponatremia (<135 mmol/L), in-
crease in urine sodium concentration (>18 mmol/L),
large urine volume (>3000 mL/d), and low blood volume
[23], 2) urine osmolality/plasma osmolality >1, reduced
plasma osmolality (<270 mmol/kg H2O) and natremia
(<137 mmol/l) combined with polyuria (>150 % of
fluid intake) and clinical and biochemical signs of re-
duced extracellular volume [18], and 3) serum sodium
level <136 mEq/L that required additional sodium re-
tention therapy and massive sodium excretion with
negative sodium and water in-out balances [13]. The
remaining three cohort studies used varying sodium
levels as a start – <130 mEq/L [11], ≤ 130 mEq/l [12],
and <135 mmol/l [14] – and then evaluated clinical
data, though did not report pre-defined values that
would qualify as CSW. Due to varying study inclusion
and CSW diagnostic criteria, we did not perform a
pooled data analysis.
Timing from traumatic brain injury to development of
cerebral salt wasting
The timing from injury to the development of CSW
appears to vary. Lohani et al. found hyponatremia oc-
curred late in the first week and early in the second
week after injury [11], whereas Moro et al. reported that
most patients presented with hyponatremia within 3 days
of injury [13]. Neither of these cohort studies indicated
when surgery was performed relevant to development
of hyponatremia [26] or specifically reported the time
from injury to the development of CSW. Eight pediatric
and 2 adult cases of CSW were presented (Additional
file 2). In the pediatric patients, three developed CSW 2
days after injury [17, 22, 25], two developed CSW ap-
proximately 1 week after injury [17, 20], and three de-
veloped CSW between 2 weeks and 2 months after
36 Records through 
database search
11 records through 
footnote search
47 total records
26 full text articles 
assessed for eligibility
15 full text articles 
included in review
0 records through 
conference abstracts 
search
11 full text articles 
excluded, with r easons:
•  Non-trauma population
•  Does not distinguish 
CSW as a cause of 
hyponatremia
• Studied only SIADH
•  Case studies of patients 
with chronic disease
21 records excluded 
after initial review
Fig. 1 PRISMA flow chart demonstrating study identification and selection process
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injury [19, 21, 24]. In the adult cases, one patient’s
CSW occurred approximately 1 week post-injury [16]
and the other adult case did not specify time between
injury and CSW, though it was noted that CSW oc-
curred within 24 h after ending their pentobarbital in-
fusion [15].
Biochemical changes
Table 1 summarizes select hormones reported in the
included studies. Three case studies reported in-
creased levels of ANP [20–22], while one case study
and one prospective study reported no increase in
ANP amongst patients who developed CSW [23, 24].
Lu et al. described two cases of CSW with elevated
BNP levels [16]; however, two prospective studies [12, 23]
and one additional case report [24] found no correl-
ation between BNP and serum sodium level. ADH
was normal [12, 23] or decreased [14, 21] in patients
with CSW after TBI. Donati-Genet et al. described a
CSW case in which the ADH was initially increased,
but rapidly normalized after volume and sodium sup-
plementation [20]. Aldosterone levels were normal
[12] or decreased [20–22], cortisol and ACTH were
within a normal range [19–21, 24], and plasma renin
activity was decreased [20–22] in patients who devel-
oped CSW after TBI.
Outcomes
All of the case reports provided information on clin-
ical outcomes; of those, one patient (10 %) died [16]
and the remaining nine improved. Prior to their CSW
diagnosis, two patients developed seizures [19, 20].
The cohort studies often described the incidence, eti-
ology, and biochemical changes observed in patients,
but few reported patient outcomes. Lohani et al.
reported no significant difference in hospital length of
stay (LOS, p = 0.83) or Glasgow Outcome Scale (GOS,
p = 0.55) at discharge for hyponatremic versus non-
hyponatremic patients [11]. Moro et al. found hypo-
natremia was associated with longer LOS (p < .001)
and a bad outcome (severe disability, vegetative state,
or death on GOS) 1 month after hospital discharge
(p = 0.02) [13]. Neither study reported outcomes spe-
cifically for CSW patients.
Discussion
This review focuses on the CSW literature within the
TBI population. We found much uncertainty surround-
ing CSW. In particular, the reported incidence of CSW
is wide. Small study size and varying populations, study
inclusion, and CSW diagnostic criteria may contribute
to the wide range in incidence. Hyponatremia is typically
noted before CSW is suspected. Among cohort studies
in this review, criteria to diagnose CSW or SIADH in-
cluded natremia levels of 130 [11, 12], 135 [14, 23], 136
[13], and 137 mmol/L [18]. To confidently diagnose
CSW, regardless of etiology, we believe the following cri-
teria must be met:
1. Brain Pathology: new in onset or severity and
defined by neurologic exam, neuro-imaging, cerebral
spinal fluid examination, laboratory testing, or
electroencephalogram. Vacillation in the neurologic
assessment should track with indices of sodium and
water balance.
2. Hyponatremia: validated by at least one simultaneously
low serum osmolality.
3. Hypovolemia: clinical assessment of intravascular
volume is difficult to accomplish, yet needs to be
assessed.
Table 1 Summary of select hormones in patients who developed cerebral salt wasting after traumatic brain injury
Author ANP BNP ADH Aldosterone Cortisol ACTH Plasma renin activity
Cohort Studies
Costa [12] Normal Normal Normal




Askar [24] Normal Normal Normal
Lu [16] ↑
Donati-Genet [20] ↑ ↑a ↓ Normal Normal ↓
Kappy [21] ↑ ↓ ↓ Normal ↓
Ganong [22] ↑ ↓ ↓
ANP atrial natriuretic peptide, BNP Brain natriuretic peptide, ADH Antidiuretic hormone, ACTH Adrenocorticotropic hormone
a rapidly normalized after volume and sodium supplementation
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4. Urinary salt loss: Two caveats apply; first, a high
urine sodium does not prove net salt loss, which
can only be calculated by knowing the volume and
sodium concentration of urine during an interval of
time and comparing it to sodium intake for that
same period. Second, a salt loss in excess of salt
intake would not be “wastage” if the patient had
prior extracellular fluid expansion that induced a
“corrective” natriuresis.
Implicit in the diagnosis of CSW is the reasonable cer-
tainty that other known causes of renal salt loss have
been excluded. The following is a far from exhaustive list
of clinically important factors to consider when deter-
mining if a patient is experiencing CSW:
1. Fluid overload from initial resuscitation.
2. Episodic catecholamine surges induced by central
nervous system injury that can increase blood
pressure, cause pressure natriuresis, and cause
vasoconstriction of capacitance vessels [27].
3. When co-existent cervical spinal cord injury with
tetraplegia exists, the position of the patient when
tested is critical. Greater natriuresis and aquaresis
occur when supine and are attenuated when
upright [28].
4. Adrenal insufficiency must be excluded, with special
emphasis on mineralocorticoid insufficiency.
5. Intrinsic renal tubular injury must be excluded. To
implicate acute kidney injury as a cause of urinary
salt wastage requires tests of greater sensitivity and
specificity than blood urea nitrogen or creatinine,
which reflect glomerular rather than renal tubular
function. The renal assessment should include
fractional excretions of sodium, chloride, phosphate,
and urate and could include tests of tubular
proteinuria and aminoaciduria.
6. An ever-increasing number of medications will
alter renal tubular function, including diuretics,
osmotic agents, intravenous radiocontrast, topiramate,
aminoglycosides, caffeine, theophylline, and
guaifenisin.
Adding to the ambiguity in diagnosing CSW is the un-
certainty surrounding the mechanisms causing CSW. It
has been suggested CSW takes a different course in
adults compared to children, with CSW being a delayed
phenomenon in adults [17, 29] and developing earlier in
children [17]. Our review resulted in few adult cases
making it difficult to compare the timing from injury to
CSW in adults; however, within children we found var-
ied times to onset. The timing from injury to onset of
CSW may be indicative of more than one pathophysi-
ology causing CSW after TBI [13], with pathways
influenced by the type and location of injury, as well as
physiological differences between adults and children.
The leading theory purports increased levels of natri-
uretic peptides and changes in the sympathetic nervous
system contribute to the development of CSW [4, 7, 29].
ANP, BNP, C type natriuretic peptide (CNP), and den-
droaspis natriuretic peptide (DNP) have been associated
with CSW [7]. These hormones inhibit sympathetic out-
flow and the production of vasoconstrictor peptides, in-
hibit the renin-angiotensin-aldosterone system, and act
as vasodilators [30]. After intracranial insult the natri-
uretic peptides may increase because of atrial stretch
and increased ventricular load from surges in sympa-
thetic outflow [31], direct damage to the brain structures
housing BNP involuntarily releasing the peptide into cir-
culation [7] and, the hypothalamus, which may generate
and release ANP and BNP as a protective mechanism
against rising intracranial pressure and potential un-
favorable outcomes [32].
While elevated levels of ANP [33, 34] and BNP
[31, 32, 35] have been reported in aSAH patients, we
found neither ANP nor BNP unfailingly increased in
TBI patients with CSW [20–24]. Interestingly, head
CT scans revealed bleeds in the two cases with ele-
vated BNP. Though reported to be smaller bleeds
than typically seen with aSAH, it cannot be ruled out
that the hemorrhage was responsible for increased
levels of BNP [16]. In the studies with elevated ANP
[20–22], aldosterone was decreased, which may reflect
ANP inhibiting the renin-angiotensin-aldosterone sys-
tem [30].
Still, additional mechanisms causing CSW warrant
study. Kojima et al. suggested the cause of CSW is nei-
ther ANP, BNP, nor ADH, but rather a novel mechanism
or endogenous compound [36].
Limitations
Our review has several limitations. Few studies ad-
dressed CSW in the TBI population and those that do
are of relatively low quality. We found just fifteen publi-
cations eligible for inclusion in our study, nine of which
were case reports. Patient populations were heteroge-
neous and diagnostic criteria used to define CSW varied
to such a wide extent that we found it necessary to take
at face value what others defined as CSW. Very import-
antly, little information was reported on TBI patient out-
comes after developing CSW.
Conclusions
Although the mechanisms are poorly understood, it is
recognized that distinguishing CSW from SIADH and
other etiologies of hyponatremia is important when
treating patients with brain injuries. We found the inci-
dence and timing of CSW varies widely in TBI patients,
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from 0.8–34.6 % and develops within days to two
months post-injury. While theories exist, the mecha-
nisms of CSW are unclear and the association of natri-
uretic peptides is inconsistently reported. The TBI
population is complicated as TBIs arise from various
and diverse initial insults, occur in patients of all ages,
and may result in contusions, hemorrhages, or edema.
The confounding factors highlighted in this review, in
combination with the disparate incidence, emphasize the
exigency for strict and consistent diagnostic criteria for
CSW, not only to be used clinically, but also when pre-
senting research pertaining to CSW. Only then can we
gain a better understanding of CSW, the most elusive of
the causes of hyponatremia.
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